Correction: Combination of Itacitinib or Parsaclisib with Pembrolizumab in Patients with Advanced Solid Tumors: A Phase I Study.

Munster, Pamela; Iannotti, Nicholas; Cho, Daniel C; Kirkwood, John M; Villaruz, Liza C; Gibney, Geoffrey T; Hodi, F Stephen; Mettu, Niharika B; Jones, Mark; Bowman, Jill; Smith, Michael; Lakshminarayanan, Mani; O'Day, Steven

Munster, Pamela; Iannotti, Nicholas; Cho, Daniel C; Kirkwood, John M; Villaruz, Liza C; Gibney, Geoffrey T; Hodi, F Stephen; Mettu, Niharika B; Jones, Mark; Bowman, Jill; Smith, Michael; Lakshminarayanan, Mani; O'Day, Steven.

Cancer Res Commun ; 4(3): 785, 2024 Mar 13.

Article en En | MEDLINE | ID: mdl-38477691

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10936421
https://dx.doi.org/10.1158/2767-9764.CRC-24-0133

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Res Commun Año: 2024 Tipo del documento: Article

Texto completo

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10936421
https://dx.doi.org/10.1158/2767-9764.CRC-24-0133

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Cancer Res Commun Año: 2024 Tipo del documento: Article